Janux Therapeutics Competitors and Similar CompaniesClear all

Janux Therapeutics's competitors and similar companies include OncoTherapy Science, Bexion Pharmaceuticals, Calidi Biotherapeutics and Iksuda Therapeutics.

	Janux Therapeutics Janux Therapeutics is a biopharmaceutical company developing therapeutics to treat patients with cancer.	OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics.	Bexion Pharmaceuticals Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments.	Calidi Biotherapeutics Calidi Biotherapeutics is a company that specializes in oncolytic virus-based immunotherapies for cancer.	Iksuda Therapeutics Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer.
Founding Date	Founding Date 2017	Founding Date 2001	Founding Date 2006	Founding Date 2014	Founding Date 2007
Type	Type Public	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy
Locations	Locations San Diego, US HQ	Locations Kawasaki, JP HQ	Locations Covington, US HQ	Locations San Diego, US HQ Bernried, DE	Locations Newcastle upon Tyne, GB HQ Newton, US
Employees	Employees 20	Employees 54	Employees 274% increase	Employees 327% increase	Employees 43
Valuation ($)	Valuation ($) 2.8 b	Valuation ($) 56.9 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $10m (FY, 2025)	Revenue (est.) ¥808.5m (FY, 2026)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income ($113.6m) (FY, 2025)	Net income (¥910.6m) (FY, 2026)	Net income N/A	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 16.6m (about 7 years ago)	Latest funding round $ 8.2m (over 6 years ago)	Latest funding round $ 47m (almost 5 years ago)
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 16.6m	Total funding raised $ 20m	Total funding raised $ 47m